# Lippia Alba for Migraine Prophylaxis and Treatment

> **NCT01259947** · PHASE2 · COMPLETED · sponsor: **Fabio Carmona** · enrollment: 60 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Lippia alba (Mill.) N. E. Brown ethanolic extract

## Key facts

- **NCT ID:** NCT01259947
- **Lead sponsor:** Fabio Carmona
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2010-04
- **Final completion:** 2010-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01259947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01259947, "Lippia Alba for Migraine Prophylaxis and Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01259947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*